Pathogenesis of malignant mesothelioma

Clinical Lung Cancer

Volumn 5, Issue SUPPL. 2, 2004, Pages

  Carbone, Michele ^a   Rdzanek, Monica A ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Asbestos; Chrysotile; Crocidolite; Simian virus 40; T antigen

Indexed keywords

ASBESTOS; CANCER VACCINE; CARCINOGEN; CHRYSOTILE; CROCIDOLITE; ERIONITE; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; VIRUS SMALL T ANTIGEN; VIRUS VACCINE;

ARTICLE; BUILDING MATERIAL; CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; CARCINOGENICITY; DNA VIRUS; ELECTRON MICROSCOPY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEREDITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT MESOTHELIOMA; NONHUMAN; PLEURA MESOTHELIOMA; SIMIAN VIRUS 40; SURVIVAL TIME; TURKEY (REPUBLIC);

EID: 2342555693     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2004.s.002     Document Type: Article

References (37)

1. Case Records of the Massachusetts General Hospital (case 331111). N Engl J Med 1947; 236:407-412.
2. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol 2002; 29:2-17.
3. Ordonez NG. Immunohistochemical diagnosis of epithelioid mesotheliomas: a critical review of old markers, new markers. Hum Pathol 2002; 33:953-967.
4. Miettinen M, Sarlomo-Rikala M. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura. Am J Surg Pathol 2003; 27:150-158.
5. Carbone M, Rizzo P, Powers A, et al. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications. Anticancer Res 2002; 22:3443-3448.
6. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157:1666-1680.
7. Churg A. Asbestos lung burden and disease patterns ni man. In: Githrie GD, Mossman BT, eds. Health Effects of Mineral Dusts. Chelsea, MI: BookCrafters, 1993:409-426.
8. Smith WE, Hubert DD. The intrapleural route as a means of estimating carcinogenicity. In: Karbe E, Parke JF, eds, eds. Experimental Lung Cancer Carcinogenesis and Biostatistics. New York, NY: Springer Verlag, 1974:92-101.
9. Gibbs AR, Pooley FD. Analysis and interpretation of inorganic mineral particles in "lung" tissues. Thorax 1996; 51:327-334.
10. Wagner JC, Berry G, Skidmore JW, et al. The effects of the inhalation of asbestos in rats. Br J Cancer 1974; 29:252-269.
11. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med 1992; 34:718-721.
12. Choe N, Tanaka S, Xia W, et al. Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ Health Perspect 1997; 105(suppl 5):S1257-S1260.
13. Tanaka S, Choe N, Iwagaki A, et al. Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp Lung Res 2000; 26:241-255.
14. Choe N, Tanaka S, Kagan E. Asbestos fibers and interleukin-1 upregulate the formation of reactive nitrogen species in rat pleural mesothelial cells. Am J Respir Cell Mol Biol 1998; 19:226-236.
15. Tanaka S, Choe N, Hemenway DR, et al. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. J Clin Invest 1998; 102:445-454.
16. Choe N, Zhang J, Iwagaki A, et al. Asbestos exposure upregulates the adhesion of pleural leukocytes to pleural mesothelial cells via VCAM-1. Am J Physiol 1999; 277:L292-300.
17. Mossman BT, Gruenert DC. SV40, growth factors, and mesothelioma: another piece of the puzzle. Am J Respir Cell Mol Biol 2002; 26:167-170.
18. Dawson A, Gibbs AR, Pooley FD, et al. Malignant mesothelioma in women. Thorax 1993; 48:269-274.
19. Heller DS, Gordon RE, Clement PB, et al. Presence of asbestos in peritoneal malignant mesotheliomas in women. Int J Gynecol Cancer 1999; 9:452-455.
20. Schneider J, Straif K, Woitowitz HJ. Pleural mesothelioma and household asbestos exposure. Rev Environ Health 1996; 11:65-70.
21. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002; 2:957-964.
22. Hirvonen A, Mattson K, Karjalainen A, et al. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog 1999; 26:93-99.
23. Emri S, Kocagoz T, Olut A, et al. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res 2000; 20:891-894.
24. Leithner A, Weinhaeusel A, Windhager R, et al. Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. Cancer Biol Ther 2002; 1:375-379.
25. Ferber D. Virology. Monkey virus link to cancer grows stronger. Science 2002; 296:1012-1015.
26. Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000; 97:10214-10219.
27. Shivapurkar N, Wiethege T, Wistuba, II, et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 1999; 76:181-188.
28. Carbone M, Rizzo P, Grimley PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997; 3:908-912.
29. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993; 142:1524-1533.
30. Gannon JV, Lane DP. p53 and DNA polymerase alpha compete for binding to SV40 T antigen. Nature 1987; 329:456-458.
31. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol 2001; 11:31-38.
32. Toyooka S, Pass HI, Shivapurkar N, et al. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res 2001; 61:5727-5730.
33. Foddis R, De Rienzo A, Broccoli D, et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002; 21:1434-1442.
34. Roushdy-Hammady I, Siegel J, Emri S, et al. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001; 357:444-445.
35. Roggli VL, Sanders LL. Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg 2000; 44:109-117.
36. Amin AM, Mason C, Rowe P. Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy. Eur J Surg Oncol 2001; 27:214-215.
37. Imperiale MJ, Pass HI, Sanda MG. Prospects for an SV40 vaccine. Semin Cancer Biol 2001; 11:81-85.